This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval for a new indication for use for the d-stat flowable hemostat. The device is indicated for use in high-risk anti-coagulated patients undergoing implantation of a pulse generator (e. G. , pacemaker or icd) to reduce the frequency of clinically relevant hematoma formation in the prepectoral pocket. D-stat flowable is indicated for use in high-risk anti-coagulated patients undergoing implantation of a pulse generator (e. G. , pacemaker or icd to reduce the frequency of clinically relevant hematoma formation in the prepectoral pocket. High-risk patients are defined as those whose anti-coagulation regimens will resume within 24 hours of implant. Clinically relevant hematomas are defined as those that result in an alteration in the standard of care resultant of hematoma formation including alteration (i. E. Suspension or discontinuation) of the anticoagulant therapy regimen (heparin, lmwh, warfarin, or clopidogrel), application of a compression bandage and evacuation of the hematoma.
Device | VASCULAR SOLUTIONS D-STAT FLOWABLE HEMOSTAT |
Classification Name | Device, Hemostasis, Vascular |
Generic Name | Device, Hemostasis, Vascular |
Applicant | Vascular Solutions, Inc. |
Date Received | 2006-06-22 |
Decision Date | 2006-12-22 |
Notice Date | 2007-05-11 |
PMA | P990037 |
Supplement | S024 |
Product Code | MGB |
Docket Number | 07M-0188 |
Advisory Committee | Cardiovascular |
Supplement Type | Panel Track |
Supplement Reason | Change Design/components/specifications/material |
Expedited Review | No |
Combination Product | No |
Applicant Address | Vascular Solutions, Inc. 6464 Sycamore Court North minneapolis, MN 55369 |
Summary: | Summary of Safety and Effectiveness |
Labeling: | Labeling |
Approval Order: | Approval Order |
Supplement Number | Date | Supplement Type |
---|---|---|
P990037 | Original Filing | |
S036 | 2022-08-08 | Normal 180 Day Track |
S035 | 2021-06-14 | 30-day Notice |
S034 | 2016-09-09 | 30-day Notice |
S033 | ||
S032 | 2016-01-29 | Special (immediate Track) |
S031 | 2010-07-30 | Normal 180 Day Track No User Fee |
S030 | 2010-04-09 | 30-day Notice |
S029 | 2009-11-04 | 30-day Notice |
S028 | 2008-10-21 | Real-time Process |
S027 | ||
S026 | 2008-07-11 | 30-day Notice |
S025 | 2007-06-14 | Special (immediate Track) |
S024 | 2006-06-22 | Panel Track |
S023 | 2005-08-05 | Special (immediate Track) |
S022 | 2004-06-15 | Normal 180 Day Track No User Fee |
S021 | 2004-06-15 | Real-time Process |
S020 | 2003-06-18 | 30-day Notice |
S019 | 2003-05-16 | Real-time Process |
S018 | 2003-04-30 | Normal 180 Day Track No User Fee |
S017 | ||
S016 | ||
S015 | 2003-03-11 | Real-time Process |
S014 | 2003-02-24 | Special (immediate Track) |
S013 | 2003-01-23 | 30-day Notice |
S012 | 2003-01-17 | Real-time Process |
S011 | 2002-08-26 | 30-day Notice |
S010 | 2002-02-27 | Normal 180 Day Track |
S009 | 2002-03-15 | Real-time Process |
S008 | 2001-12-11 | Normal 180 Day Track |
S007 | 2001-11-28 | Special (immediate Track) |
S006 | 2001-05-21 | Special (immediate Track) |
S005 | 2001-05-01 | Normal 180 Day Track |
S004 | ||
S003 | 2001-02-07 | Real-time Process |
S002 | 2001-01-22 | Real-time Process |
S001 | 2000-10-04 | Normal 180 Day Track |